Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LVTX |
---|---|---|
09:32 ET | 1272 | 2.36 |
09:39 ET | 400 | 2.36 |
09:41 ET | 400 | 2.36 |
09:43 ET | 800 | 2.36 |
09:45 ET | 800 | 2.37 |
09:48 ET | 400 | 2.37 |
09:50 ET | 400 | 2.37 |
09:52 ET | 765 | 2.36 |
09:54 ET | 4962 | 2.37 |
09:56 ET | 100 | 2.37 |
09:57 ET | 4110 | 2.37 |
10:14 ET | 5370 | 2.38 |
10:15 ET | 100 | 2.38 |
10:17 ET | 100 | 2.38 |
10:19 ET | 2950 | 2.38 |
10:21 ET | 1600 | 2.38 |
10:35 ET | 2214 | 2.431 |
10:37 ET | 705 | 2.36 |
10:42 ET | 800 | 2.36 |
10:46 ET | 1000 | 2.37 |
10:48 ET | 400 | 2.37 |
10:50 ET | 400 | 2.37 |
10:51 ET | 400 | 2.37 |
10:55 ET | 650 | 2.36 |
11:00 ET | 800 | 2.355 |
11:04 ET | 1143 | 2.355 |
11:06 ET | 200 | 2.355 |
11:08 ET | 400 | 2.355 |
11:09 ET | 2300 | 2.385 |
11:11 ET | 700 | 2.355 |
11:13 ET | 400 | 2.355 |
11:15 ET | 2300 | 2.355 |
11:18 ET | 900 | 2.3425 |
11:20 ET | 287 | 2.34 |
11:22 ET | 400 | 2.35 |
11:24 ET | 2313 | 2.3475 |
11:26 ET | 500 | 2.34 |
11:27 ET | 400 | 2.33 |
11:29 ET | 2295 | 2.33 |
11:31 ET | 400 | 2.32 |
11:33 ET | 7115 | 2.32 |
11:36 ET | 200 | 2.32 |
11:38 ET | 2200 | 2.32 |
11:40 ET | 8745 | 2.32 |
11:42 ET | 2126 | 2.35 |
11:44 ET | 2474 | 2.35 |
11:45 ET | 200 | 2.37 |
11:54 ET | 1500 | 2.36 |
11:56 ET | 800 | 2.36 |
12:09 ET | 400 | 2.34 |
12:12 ET | 4960 | 2.33 |
12:14 ET | 4749 | 2.32 |
12:16 ET | 200 | 2.32 |
12:18 ET | 400 | 2.32 |
12:20 ET | 200 | 2.32 |
12:21 ET | 2119 | 2.32 |
12:23 ET | 7171 | 2.3 |
12:27 ET | 676 | 2.3 |
12:30 ET | 1256 | 2.25 |
12:32 ET | 200 | 2.25 |
12:34 ET | 3363 | 2.28 |
12:39 ET | 400 | 2.33 |
12:48 ET | 1600 | 2.32 |
12:50 ET | 1125 | 2.31 |
12:54 ET | 1200 | 2.305 |
12:56 ET | 1300 | 2.29 |
12:57 ET | 700 | 2.26 |
12:59 ET | 200 | 2.26 |
01:01 ET | 200 | 2.26 |
01:03 ET | 1400 | 2.26 |
01:06 ET | 200 | 2.26 |
01:08 ET | 200 | 2.26 |
01:10 ET | 2500 | 2.2999 |
01:12 ET | 400 | 2.27 |
01:14 ET | 200 | 2.285 |
01:15 ET | 377 | 2.27 |
01:17 ET | 300 | 2.29 |
01:19 ET | 200 | 2.26 |
01:21 ET | 200 | 2.26 |
01:24 ET | 200 | 2.26 |
01:26 ET | 400 | 2.26 |
01:28 ET | 200 | 2.26 |
01:30 ET | 197 | 2.26 |
01:32 ET | 1400 | 2.29 |
01:33 ET | 200 | 2.26 |
01:35 ET | 2191 | 2.27 |
01:37 ET | 400 | 2.26 |
01:39 ET | 100 | 2.26 |
01:42 ET | 500 | 2.265 |
01:44 ET | 200 | 2.25 |
01:46 ET | 200 | 2.25 |
01:48 ET | 200 | 2.25 |
01:50 ET | 300 | 2.265 |
01:51 ET | 400 | 2.25 |
01:53 ET | 400 | 2.25 |
01:55 ET | 300 | 2.25 |
01:57 ET | 500 | 2.25 |
02:00 ET | 400 | 2.25 |
02:02 ET | 200 | 2.25 |
02:04 ET | 400 | 2.25 |
02:06 ET | 393 | 2.25 |
02:08 ET | 12586 | 2.26 |
02:24 ET | 300 | 2.26 |
02:26 ET | 300 | 2.25 |
02:27 ET | 300 | 2.25 |
02:29 ET | 300 | 2.25 |
02:31 ET | 400 | 2.25 |
02:33 ET | 300 | 2.25 |
02:36 ET | 300 | 2.25 |
02:38 ET | 300 | 2.25 |
02:40 ET | 300 | 2.25 |
02:42 ET | 300 | 2.25 |
02:44 ET | 300 | 2.25 |
02:45 ET | 300 | 2.25 |
02:47 ET | 300 | 2.25 |
02:49 ET | 300 | 2.25 |
02:54 ET | 600 | 2.25 |
02:56 ET | 300 | 2.25 |
02:58 ET | 9426 | 2.2988 |
03:00 ET | 5880 | 2.375 |
03:09 ET | 12300 | 2.41 |
03:12 ET | 1500 | 2.44 |
03:14 ET | 12877 | 2.39 |
03:18 ET | 1016 | 2.38 |
03:27 ET | 906 | 2.31 |
03:32 ET | 600 | 2.37 |
03:34 ET | 700 | 2.25 |
03:38 ET | 800 | 2.25 |
03:39 ET | 600 | 2.25 |
03:41 ET | 600 | 2.25 |
03:43 ET | 600 | 2.25 |
03:45 ET | 600 | 2.25 |
03:48 ET | 1900 | 2.3565 |
03:50 ET | 600 | 2.35 |
03:52 ET | 400 | 2.31 |
03:54 ET | 800 | 2.3 |
03:56 ET | 2200 | 2.2543 |
03:57 ET | 1415 | 2.315 |
03:59 ET | 3716 | 2.26 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
LAVA Therapeutics NV | 59.4M | -2.1x | --- |
Kezar Life Sciences Inc | 50.5M | -0.5x | --- |
BioLine RX Ltd | 58.4M | -1.0x | --- |
Kronos Bio Inc | 47.5M | -0.4x | --- |
DURECT Corp | 53.1M | -2.0x | --- |
Atara Biotherapeutics Inc | 67.5M | -0.3x | --- |
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $59.4M |
---|---|
Revenue (TTM) | $12.5M |
Shares Outstanding | 26.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.07 |
Book Value | $1.95 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 4.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -252.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.